11 Aug 2020Ended 5.0 1 Ratings

Assessment of Potential Drug-Drug Interactions from In Vitro Experiments to PBPK Modeling


Estimated Turnout

100 - 500
Based on previous editions


11 Aug 2020


Not Available
Claim event to edit details

Join this free webinar to learn more about the assessment of drug-drug interactions using static and PBPK models, and in accordance to the FDA’s .. Read more new regulatory guidelines. The FDA recently approved updated regulatory guidance for drug-drug interactions (DDIs). This webinar will focus on how to follow the FDA guidance, design in vitro studies, interpret the data and assess potential drug-drug interactions, using both static and Physiologically Based Pharmacokinetic (PBPK) models. Co-administration of multiple drugs may potentially cause a drug-drug interaction (DDI) in which one drug alters the exposure of another, resulting in either therapeutic failure or risk of a patient’s life. Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives. Covance is a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services.

  • Followers
  • [ Users who have shown interest for this Event ]
Jose Joaquin Merino

Jose Joaquin Merino

Researcher at UCM

Madrid, Spain
  • Share your Experience

1 Ratings
5   1

  • Organizer
Logo Follow Company


Canada 183 Total Events / 8 Upcoming Events

More Events From The Organizer